Small Bone Innovations International SAS has entered into an exclusive three-year distribution agreement in the Netherlands with Biomet Nederland, a subsidiary of Dordrecht based Biomet.

Small Bone Innovations, an orthopedic company focused on small bones and joints treatments, has closed on $12m in Series E funding from Olympus Corporation in March 2010 and earlier secured a $30mm debt facility from Fortress Investment Group to fund accelerated business expansion and refinance existing indebtedness.

Small Bone Innovations chairman and CEO Anthony Viscogliosi said that they are delighted to expand distribution of products in the Netherlands through Biomet, a global provider of orthopedic devices.

“This announcement follows the distribution agreement announced in May of this year between SBi and Olympus Terumo Biomaterials Corporation, jointly owned by Olympus Corporation and Terumo Corporation, for Japan and China,” Viscogliosi said.

Biomet Nederland managing director Roland van Esch said that they are eager to offer SBi’s full product line in the Netherlands that both complements and supplements Biomet’s European product line.